Project Grant HT94252410721
Award Date 9/1/24
Completion Date 8/31/26
Dollars Obligated $460K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Madison, WI 53715, USA
Similar Awards
- This $1,251,230 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports breast cancer research by the University of Wisconsin System, with the University of Wisconsin-Madison as the lead institution. The award, effective June 15, 2025, will fund a four-year collaborative research project focused on breakthrough advancements in breast cancer clinical trials. The research aims to develop innovative medical solutions to...
- The University of Wisconsin System was awarded a $1,555,000 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on population modeling to optimize equitable ovarian cancer outcomes. The grant project will take place in Madison, WI from April 15, 2025 to April 14, 2029. This federal grant program supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the...
- This federal Project Grant award, valued at $155,500.00 and provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, is for the University of Wisconsin System to develop a model to study tumor-normal cell interaction in vitro for high-throughput drug screening. The research aims to transform healthcare for military service members and the broader public through innovative biomedical investigations. The one-year project will run from...
- This $777,500 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports multiomic analysis of liquid biopsies for biomarker discovery and therapeutic targeting at the University of Wisconsin-Madison. The project aims to transform healthcare for military service members, veterans, and the broader public through advanced biomedical research. The 3-year project, commencing on June 1, 2025, will leverage the university's...
- This federal Project Grant award of $1,146,270.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Wisconsin System. The grant supports research targeting a lipid kinase regulator of nuclear AKT in breast cancer, with a performance period from July 15, 2023 to July 14, 2026. The University of Wisconsin System, through its University of Wisconsin - Madison division, will conduct this biomedical research to...
- This Project Grant award for $699,750 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) to the University of Washington aims to support the discovery and characterization of tissue-specific regulatory mutations that predispose to ovarian cancer. The award will fund research activities over a 3-year period from April 2024 to March 2027. As a leading research university, the University of Washington has extensive experience managing federal grants and...
- This $1,074,650.00 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) is supporting research by the University of Wisconsin System to investigate the immunomodulatory effects of chemokine signaling in renal cell carcinoma. The award has a performance period from September 1, 2025 to August 31, 2029 and will fund advanced biomedical research efforts to transform healthcare for military service members, veterans, and the broader...
- This $729,778 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) to the University of Wisconsin System supports a multiomic analysis of liquid biopsies for biomarker discovery and therapeutic targeting. The research, which will take place at the University of Wisconsin-Madison between June 1, 2025 and May 31, 2028, aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative...
- The federal Project Grant award of $932,918 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) is supporting research at the University of Washington to determine the role of somatic mosaicism in ovarian cancer predisposition. The grant, awarded on September 30, 2024 with an ultimate completion date of September 29, 2028, will enable the University of Washington to conduct innovative scientific studies to improve health outcomes for military...
- This Project Grant award of $465,935.00, provided by the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development), supports research by the University of Wisconsin System (UEI: LCLSJAGTNZQ7) to combine 225AC-PSMA and BRD4 disruption approaches to overcome resistance in advanced prostate cancer. The research project will be conducted at the University of Wisconsin-Madison from August 1, 2025, through July 31, 2027. The funding aims to advance biomedical research that...